相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs
Diana Duarte et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Old wine in new bottles: Drug repurposing in oncology
Michal Antoszczak et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
Alan Talevi et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
SynergyFinder 2.0: visual analytics of multi-drug combination synergies
Aleksandr Ianevski et al.
NUCLEIC ACIDS RESEARCH (2020)
New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells
Diana Duarte et al.
BIOMOLECULES (2020)
Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead
Rashmi R. Shah et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2019)
New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer
Anushka Dongre et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
β-Catenin expression is associated with cell invasiveness in pancreatic cancer
Jin Niang Nan et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2019)
Synergistic effect of thymoquinone and melatonin against breast cancer implanted in mice
Lena Hisham Odeh et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
Apoptosis induction in human breast cancer cell lines by synergic effect of raloxifene and resveratrol through increasing proapoptotic genes
Pegah Mirzapur et al.
LIFE SCIENCES (2018)
Recent progress in synergistic chemotherapy and phototherapy by targeted drug delivery systems for cancer treatment
Jie Cao et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Curcumin and paclitaxel induce cell death in breast cancer cell lines
Gloria M. Calaf et al.
ONCOLOGY REPORTS (2018)
ReDO_DB: the repurposing drugs in oncology database
Pan Pantziarka et al.
ECANCERMEDICALSCIENCE (2018)
Trifluoperazine, a Well-Known Antipsychotic, Inhibits Glioblastoma Invasion by Binding to Calmodulin and Disinhibiting Calcium Release Channel IP3R
Seokmin Kang et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Aromatase inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide moiety as hybrid molecules
Mostafa M. Ghorab et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synergistic cytotoxic effects of arsenite and tetrandrine in human breast cancer cell line MCF-7
Mingjiang Yao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
Angela M. Krebs et al.
NATURE CELL BIOLOGY (2017)
Combination therapy in combating cancer
Reza Bayat Mokhtari et al.
ONCOTARGET (2017)
Evaluation of cell death pathways initiated by antitumor drugs melatonin and valproic acid in bladder cancer cells
Siwei Liu et al.
FEBS OPEN BIO (2017)
An Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines
Kyle R. Roell et al.
FRONTIERS IN PHARMACOLOGY (2017)
Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells
Jonathan Metts et al.
SCIENTIFIC REPORTS (2017)
Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy
Adam C. Palmer et al.
CELL (2017)
Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation
W-H Yang et al.
ONCOGENE (2016)
Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression
Manuela Terranova-Barberio et al.
ONCOTARGET (2016)
Recent advances of cocktail chemotherapy by combination drug delivery systems
Quanyin Hu et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Inhibition of FoxM1-Mediated DNA Repair by Imipramine Blue Suppresses Breast Cancer Growth and Metastasis
Subapriya Rajamanickam et al.
CLINICAL CANCER RESEARCH (2016)
Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia
Kamilla M. E. Laidlaw et al.
ONCOTARGET (2016)
Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents-A drug repurposing strategy
Chia-Hsien Wu et al.
SCIENTIFIC REPORTS (2016)
P-cadherin and the journey to cancer metastasis
Andre Filipe Vieira et al.
MOLECULAR CANCER (2015)
Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
Xin Ye et al.
NATURE (2015)
Drug repurposing in oncology-patient and health systems opportunities
Francesco Bertolini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
P-cadherin linking breast cancer stem cells and invasion: a promising marker to identify an intermediate/metastable EMT state
Ana Sofia Ribeiro et al.
FRONTIERS IN ONCOLOGY (2015)
The contribution of TGF-β in Epithelial-Mesenchymal Transition (EMT): Down-regulation of E-cadherin via snail
H. Yu et al.
NEOPLASMA (2015)
Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions
Fei Guo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Harnessing the lysosome-dependent antitumor activity of phenothiazines in human small cell lung cancer
D. Zong et al.
CELL DEATH & DISEASE (2014)
Clinical significance of epithelial-mesenchymal transition
Konrad Steinestel et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2014)
High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion
Laura Lehtinen et al.
ONCOTARGET (2013)
Regulatory networks defining EMT during cancer initiation and progression
Bram De Craene et al.
NATURE REVIEWS CANCER (2013)
The roles of TGFβ in the tumour microenvironment
Michael Pickup et al.
NATURE REVIEWS CANCER (2013)
Trifluoperazine, an Antipsychotic Agent, Inhibits Cancer Stem Cell Growth and Overcomes Drug Resistance of Lung Cancer
Chi-Tai Yeh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Synergistic Effects of Exemestane and Aspirin on MCF-7 Human Breast Cancer Cells
Li-Xia Hu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
Anti-Invasive Adjuvant Therapy with Imipramine Blue Enhances Chemotherapeutic Efficacy Against Glioma
Jennifer M. Munson et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells
Yu-Wei Chou et al.
CANCER LETTERS (2011)
Vimentin in cancer and its potential as a molecular target for cancer therapy
Arun Satelli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Epithelial-mesenchymal transition in breast cancer progression and metastasis
Yifan Wang et al.
Chinese Journal of Cancer (2011)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Epithelial-mesenchymal transition in development and cancer
Douglas S. Micalizzi et al.
FUTURE ONCOLOGY (2009)
Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease
Herve Acloque et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Anne-Pierre Morel et al.
PLOS ONE (2008)
Carcinoma invasion and metastasis: A role for epithelial-mesenchymal transition?
EW Thompson et al.
CANCER RESEARCH (2005)
The Ca2+ channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms
GE Bertolesi et al.
MOLECULAR PHARMACOLOGY (2002)
分享论文
